lobbying_activities: 2592171

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2592171	d4feb697-d997-49e7-a496-93f43e258620	Q1	HEALTHCARE INSTITUTE OF NEW JERSEY	75251	HEALTHCARE INSTITUTE OF NEW JERSEY	2021	first_quarter	HCR	Promoting awareness of the biopharmaceutical and medical technology sectors. Opposing the imposition of price controls in the Medicare Part D program. Generally supporting intellectual property rights. Opposing H.R. 3 legislation regarding health care costs. Opposing various legislative efforts to relocate supply and logistics chains. Opposing various legislative and executive efforts to impose an international price index. Supporting the DISARM Act (S. 1712 and H.R. 4100 in the previous Congress; yet to be reintroduced). Supporting the PASTEUR Act (S. 4760 and H.R. 8920 in the previous Congress; yet to be reintroduced). Supporting the modernization of prescribing information to allow digital in lieu of printed information. Opposing CMS and CMMI Part D Payment Modernization Model amendments to Medicare's Six Protected Classes. Supporting CMS proposed rule on Medicare Coverage of Innovative Technology (MCIT).	HOUSE OF REPRESENTATIVES,SENATE		45658	0	0	2021-04-06T11:07:13.597000-04:00